![ESMO 19th World Congress on Gastrointestinal Cancer - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology ESMO 19th World Congress on Gastrointestinal Cancer - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/152168a3fd767adc1c5f7d1a33d1c4b6ee42279f/ESMO.jpg)
ESMO 19th World Congress on Gastrointestinal Cancer - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology
![Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress](https://assets.cwp.roche.com/imported/en/med-cor-2017-08-31-visual-1.2017-08-30-17-43-50.jpg)
Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress
![Fondazione Oncologia Niguarda Onlus on X: "#throwback🔙 📸ESMO 2017 dove il dottor Gianluca Mauri ha presentato i dati prodotti al Niguarda Cancer Center relativi al biomarcatore tumorale NTRK (abstract #1716P). #ospedaleniguarda #oncologianiguardaonlus Fondazione Oncologia Niguarda Onlus on X: "#throwback🔙 📸ESMO 2017 dove il dottor Gianluca Mauri ha presentato i dati prodotti al Niguarda Cancer Center relativi al biomarcatore tumorale NTRK (abstract #1716P). #ospedaleniguarda #oncologianiguardaonlus](https://pbs.twimg.com/media/EZGIojfXgAI9tnx.jpg)
Fondazione Oncologia Niguarda Onlus on X: "#throwback🔙 📸ESMO 2017 dove il dottor Gianluca Mauri ha presentato i dati prodotti al Niguarda Cancer Center relativi al biomarcatore tumorale NTRK (abstract #1716P). #ospedaleniguarda #oncologianiguardaonlus
![RS Research Announces Poster Presentation at the ESMO 2022 Congress about RS-0139's ongoing clinical trial on NSCLC - RS Research RS Research Announces Poster Presentation at the ESMO 2022 Congress about RS-0139's ongoing clinical trial on NSCLC - RS Research](https://rsresearch.net/wp-content/uploads/2022/08/ESMO.2022.jpg)